诚信认证:
工商注册信息已核实!
快速导航
产品分类
微信二维码
Minisite
细胞凋亡
R547
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
货号 | CAS号 | 操作 |
---|---|---|
R127351-5mg | 741713-40-6 | 询价 |
R127351-25mg | 741713-40-6 | 询价 |
产品介绍
- 分子式 C18H21F2N5O4S
- 分子量441.45
属性
溶解性 | Soluble in DMSO (60 mg/ml at 25 °C), water (< 1 mg/ml at 25 °C), ethanol (< 1 mg/ml at 25 °C), and 1% hydroxyethyl cellulose/0.2% Tween 80 (30 mg/ml at 25 °C). |
存贮条件 | 储存温度-20°C |
描述
应用 | A selective inhibitor of cell cycle and transcriptional cyclin dependent kinases including Cdk1, Cdk2, and Cdk4. |
产品介绍 | R547是一种有效的,ATP竞争性CDK1/2/4抑制剂,Ki为2 nM/3 nM/1 nM,对CDK7和GSK3α/β作用效果稍弱,而抑制其他激酶活性。Phase 1。 |
备注 | R547 is a potent ATP-competitive inhibitor of CDK1/2/4 with Ki of 2 nM/3 nM/1 nM. It is less potent to CDK7 and GSK3α/β, while inactive to other kinases. |
生化机理 | R547 is a novel, selective inhibitor of cell cycle and transcriptional cyclin dependent kinases including Cdk1/cyclin B, Cdk2/cyclin E, and Cdk4/cyclin D1. R547 has shown antitumor activity, and may be promising for development of a potential treatment for solid tumors. The cyclin-dependent protein kinases are key regulators of cell cycle progression; altering the expression or activity of Cdk complexes can lead to aberrant cell cycle control, leading to unrestricted cell proliferation. CDK inhibitors have the potential to induce cell cycle arrest and apoptosis in cancer cells, and identifying small-molecule CDK inhibitors has been a major focus in cancer research. |
别名 | [4-氨基-2-[(1-甲磺酰基哌啶-4-基)氨基]嘧啶-5-基](2,3-二氟-6-甲氧基苯基)甲酮;R 547;R-547;[4-Amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl](2,3-difluoro-6-methoxyphenyl)methanone |
R547信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于R547报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途